FUSION: A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ION363 in Amyotrophic Lateral Sclerosis Participants With Fused in Sarcoma Mutations (FUS-ALS)
Clinical trial NCT04768972 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04768972
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-14
- Primary completion
- 2026-06-17
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.